Cempra (CEMP) January volatility above 200 into FDA PDUFA Date
Tweet
Share
E-mailGet Alerts CEMP Hot Sheet
Join SI Premium – FREE
Cempra (NASDAQ: CEMP) January call option implied volatility is at 201, February is at 154; compared to its 52-week range of 69 to 260 into a FDA PDUFA Date for Cempra Oral Solithromycin IV formulation on December 28, 2016.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) call put ratio 1.3 calls to 1 put into quarter results
- Ross Stores (ROST) 9K contracts of September 220 puts trade into quarter results
- Palo Alto Networks (PANW) call put ratio 1 call to 1.2 puts amid price movement
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Options, PDUFA, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
